相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies
Joshua D. Rosenblat et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial
Lindsay S. Elliott et al.
PLOS ONE (2017)
Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions
O. Alagoz et al.
PHARMACOGENOMICS JOURNAL (2016)
Pharmacogenetic Tests in Psychiatry From Fear to Failure to Hype
Jose de Leon
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study
Barbara Breitenstein et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature
Elizabeth J. J. Berm et al.
PLOS ONE (2016)
Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation
Joel G. Winner et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015
Michael Bauer et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2015)
Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report
Ajeet B. Singh
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2015)
Thresholds for the cost-effectiveness of interventions: alternative approaches
Elliot Marseille et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2015)
The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study
Barbara Breitenstein et al.
CNS SPECTRUMS (2014)
Antidepressant pharmacogenetics
Ajeet B. Singh et al.
CURRENT OPINION IN PSYCHIATRY (2014)
Pharmacogenomic Testing for Neuropsychiatric Drugs: Current Status of Drug Labeling, Guidelines for Using Genetic Information, and Test Options
Katarzyna Drozda et al.
PHARMACOTHERAPY (2014)
Contribution of Common Genetic Variants to Antidepressant Response
Katherine E. Tansey et al.
BIOLOGICAL PSYCHIATRY (2013)
Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting
Daniel K. Hall-Flavin et al.
PHARMACOGENETICS AND GENOMICS (2013)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders
Michael Bauer et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2013)
Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: Update and report from a pharmacogenetic service clinic
Daniel J. Mueller et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2013)
Methods for the Drug Effectiveness Review Project
Marian S. McDonagh et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
Chapter 11: Challenges in and Principles for Conducting Systematic Reviews of Genetic Tests used as Predictive Indicators
Daniel E. Jonas et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2012)
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries
Paolo Olgiati et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Using a pharmacogenomic algorithm to guide the treatment of depression
D. K. Hall-Flavin et al.
TRANSLATIONAL PSYCHIATRY (2012)
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders
Alessandro Serretti et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2011)
Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice
Alessio Squassina et al.
PHARMACOGENOMICS (2010)
Direct-to-consumer genome testing: opportunities for pharmacogenomics research?
Barbara Prainsack et al.
PHARMACOGENOMICS (2010)
When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study
Roy H. Perlis et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
One-year clinical outcomes of depressed public sector outpatients: A benchmark for subsequent studies
AJ Rush et al.
BIOLOGICAL PSYCHIATRY (2004)
Managing depression as a chronic disease: a randomised trial of ongoing treatment in primary care
K Rost et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
分享论文
